Diagnosis and correction of immune system disorders

1986 ◽  
Vol 67 (4) ◽  
pp. 289-294 ◽  
Author(s):  
L. V. Kovalchuk ◽  
A. N. Cheredeev
Keyword(s):  
Immune System ◽  
Clinical Immunology ◽  
The State ◽  
Laboratory Evaluation ◽  
In Vitro Methods ◽  
Wide Range ◽  
High Degree

Modern clinical immunology has a wide range of tests that can detect immune system disorders with a sufficiently high degree of accuracy. Laboratory evaluation of the immune system is performed using in vivo and in vitro methods. In vivo methods allow to judge the state of the immune system at the organism level.

scholarly journals Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases

Nutrients ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 789 ◽  
Author(s):  
Mattia Bellan ◽  
Laura Andreoli ◽  
Chiara Mele ◽  
Pier Paolo Sainaghi ◽  
Cristina Rigamonti ◽  
...  
Keyword(s):  
Vitamin D ◽  
Immune System ◽  
Autoimmune Diseases ◽  
Convincing Evidence ◽  
In Vivo Studies ◽  
Human Immune System ◽  
Therapeutic Implications ◽  
Wide Range

Vitamin D is a pleiotropic secosteroid yielding multiple actions in human physiology. Besides the canonical regulatory activity on bone metabolism, several non-classical actions have been described and the ability of vitamin D to partake in the regulation of the immune system is particularly interesting, though far stronger and convincing evidence has been collected in in vitro as compared to in vivo studies. Whether vitamin D is able to regulate at physiological concentrations the human immune system remains unproven to date. Consequently, it is not established if vitamin D status is a factor involved in the pathogenesis of immune-mediated diseases and if cholecalciferol supplementation acts as an adjuvant for autoimmune diseases. The development of autoimmunity is a heterogeneous process, which may involve different organs and systems with a wide range of clinical implications. In the present paper, we reviewed the current evidences regarding vitamin D role in the pathogenesis and management of different autoimmune diseases.

In vitrotechniques as tools to predict nutrient supply in ruminants

1998 ◽  
Vol 22 ◽  
pp. 1-11 ◽  
Author(s):  
S. Tamminga ◽  
B. A. Williams
Keyword(s):  
Nutritive Value ◽  
Farm Animals ◽  
In Vitro Techniques ◽  
Evaluation Systems ◽  
In Vitro Methods ◽  
Future Developments ◽  
In Vitro Systems ◽  
High Degree

AbstractIn vitro techniques are widely used to predict the nutritive value of foods for farm animals. However, food evaluation systems are moving towards systems based on nutrient flows rather than on energy or protein. Nutrients are supplied via the digestive tract and presently available in vitro methods are inadequate to simulate the complicated and non-steady-state processes in this tract. This is partly due the lack of adequate in vivo reference values and partly due to a too-high degree of standardization and simplification. Future developments should therefore aim to develop in vitro systems which closely monitor the dynamics of the digestive processes. Adequate interpretation of the results may require sophisticated mathematical models.

RNAi-based gene therapy provides a wide variety of applications. Safe, biodegradable nano delivery vectors are still needed

2021 ◽  
Author(s):  
Moataz Dowaidar
Keyword(s):  
Clinical Trials ◽  
Target Genes ◽  
Endosomal Escape ◽  
Cell Uptake ◽  
Clinical Investigations ◽  
Wide Range ◽  
Production Techniques ◽  
High Degree

The considerable influence of siRNA and shRNA in controlling CRC by activating apoptosis and preventing CRC formation has been proven in vitro and in vivo research. Furthermore, the combined actions of inhibitors and RNAi-mediated gene knockdown may result in novel cancer therapy approaches.RNAi-based approaches give a wide range of prospective applications and a high degree of freedom to manipulate heretofore "unhackable" targets. However, in clinical investigations, RNAi medications are a major challenge to overcome. Furthermore, compared to other cancers such as melanoma, colon cancer has seen fewer clinical trials due to its tissue complexity. While new delivery strategies and materials are being investigated to increase distribution efficiency, randomized controlled trials must be done before treatment recommendations utilize RNAi. Safe, biodegradable and biocompatible NP delivery systems are still needed. Repeatable and simple batch production techniques for clinical trials and regulatory evaluations need to be created. Since unmodified siRNAs have limited cell uptake, they must be conjugated or complexed with suitable carrier systems. Furthermore, by combining siRNAs with adaptive and biocompatible nonviral carriers, the short half-life of siRNAs may be regulated due to their quick plasma and cell cytoplasm breakdown. Clinical trials should be explored with improved techniques to enhance RNAi medication encapsulation in lipid-based NPs such as liposomes or biodegradable polymers such as PLGA, cellular uptake and endosomal escape in mCRC cells. Advances in nanotechnology and medicinal chemistry may help address these issues, and adoption of RNAi-based therapeutics may increase.Another crucial part of employing RNAi-based therapeutics is finding suitable targets. Besides knowing target genes and pathways for CRC advancement, understanding modifying genes that compensate for the effect of target gene loss function and the degree of gene silence necessary is crucial.

scholarly journals Immunotoxic Effects Induced by Microcystins and Cylindrospermopsin: A Review

Toxins ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 711
Author(s):  
Leticia Diez-Quijada ◽  
Maria del Monte Benítez-González ◽  
María Puerto ◽  
Angeles Jos ◽  
Ana M. Cameán
Keyword(s):  
Immune System ◽  
Scientific Literature ◽  
Anthropogenic Activities ◽  
In Vivo Studies ◽  
Wide Range ◽  
Full Picture ◽  
Underlying Mechanisms ◽  
The Impact

Cyanotoxin occurrence is gaining importance due to anthropogenic activities, climate change and eutrophication. Among them, Microcystins (MCs) and Cylindrospermopsin (CYN) are the most frequently studied due to their ubiquity and toxicity. Although MCs are primary classified as hepatotoxins and CYN as a cytotoxin, they have been shown to induce deleterious effects in a wide range of organs. However, their effects on the immune system are as yet scarcely investigated. Thus, to know the impact of cyanotoxins on the immune system, due to its importance in organisms’ homeostasis, is considered of interest. A review of the scientific literature dealing with the immunotoxicity of MCs and CYN has been performed, and both in vitro and in vivo studies have been considered. Results have confirmed the scarcity of reports on the topic, particularly for CYN. Decreased cell viability, apoptosis or altered functions of immune cells, and changed levels and mRNA expression of cytokines are among the most common effects reported. Underlying mechanisms, however, are still not yet fully elucidated. Further research is needed in order to have a full picture of cyanotoxin immunotoxicity.

Analysis of antidepressant properties of some Papaver species by in vivo and in vitro methods

Planta Medica ◽  
2015 ◽  
Vol 81 (16) ◽  
Author(s):  
OML Bayazeid ◽  
F Yalcin ◽  
M İlhan ◽  
H Karahan ◽  
E Kupeli-Akkol ◽  
...  
Keyword(s):  
In Vitro Methods

Evaluation of 99mTc-Label led Vitamin K4 as an Agent for Testicular Imaging

1991 ◽  
Vol 30 (01) ◽  
pp. 35-39 ◽  
Author(s):  
H. S. Durak ◽  
M. Kitapgi ◽  
B. E. Caner ◽  
R. Senekowitsch ◽  
M. T. Ercan
Keyword(s):  
Soft Tissue ◽  
Room Temperature ◽  
Normal Subjects ◽  
Left Testis ◽  
Wide Range ◽  
Activity Ratios ◽  
The Right ◽  
Radioactivity Levels

Vitamin K4 was labelled with 99mTc with an efficiency higher than 97%. The compound was stable up to 24 h at room temperature, and its biodistribution in NMRI mice indicated its in vivo stability. Blood radioactivity levels were high over a wide range. 10% of the injected activity remained in blood after 24 h. Excretion was mostly via kidneys. Only the liver and kidneys concentrated appreciable amounts of radioactivity. Testis/soft tissue ratios were 1.4 and 1.57 at 6 and 24 h, respectively. Testis/blood ratios were lower than 1. In vitro studies with mouse blood indicated that 33.9 ±9.6% of the radioactivity was associated with RBCs; it was washed out almost completely with saline. Protein binding was 28.7 ±6.3% as determined by TCA precipitation. Blood clearance of 99mTc-l<4 in normal subjects showed a slow decrease of radioactivity, reaching a plateau after 16 h at 20% of the injected activity. In scintigraphic images in men the testes could be well visualized. The right/left testis ratio was 1.08 ±0.13. Testis/soft tissue and testis/blood activity ratios were highest at 3 h. These ratios were higher than those obtained with pertechnetate at 20 min post injection.99mTc-l<4 appears to be a promising radiopharmaceutical for the scintigraphic visualization of testes.

The Effects of Some Synthetic Compounds on In Vitro Fibrinolytic Activity Measured by Different Methods and the Relevance to Activity In Vivo

1972 ◽  
Vol 28 (03) ◽  
pp. 351-358
Author(s):  
A.J Baillie ◽  
A. K Sim
Keyword(s):  
Inhibitory Activity ◽  
Substrate Concentration ◽  
Fibrinolytic Activity ◽  
Synthetic Compounds ◽  
In Vitro Methods ◽  
Narrow Concentration Range

SummaryThe activity of several synthetic compounds, rated from good to poor (or inactive) fibrinolytic activators, has been assessed by two different commonly-used in vitro methods. Compounds shown to be active over a narrow concentration range in the hanging clot test were shown to be inhibitors of plasmin and trypsin in the casein-olytic test. The inhibitory activity of these compounds was shown to increase with increasing substrate concentration and apparent activity in the hanging clot test. Possible explanations and relevance of these observations are discussed.

Ethnomedicinal uses, Phytochemistry and Pharmacological Aspects of the Genus Berberis Linn: A Comprehensive Review

2020 ◽  
Vol 23 ◽  
Author(s):  
Roohi Mohi-ud-din ◽  
Reyaz Hassan Mir ◽  
Prince Ahad Mir ◽  
Saeema Farooq ◽  
Syed Naiem Raza ◽  
...  
Keyword(s):  
Chemical Constituents ◽  
Pharmacological Activities ◽  
Traditional Use ◽  
Comprehensive Review ◽  
Wide Range ◽  
Anti Cancer ◽  
Comprehensive Survey ◽  
Ethnomedicinal Uses

Background: Genus Berberis (family Berberidaceae), which contains about 650 species and 17 genera worldwide, has been used in folklore and various traditional medicine systems. Berberis Linn. is the most established group among genera with around 450-500 species across the world. This comprehensive review will not only help researchers for further evaluation but also provide substantial information for future exploitation of species to develop novel herbal formulations. Objective: The present review is focussed to summarize and collect the updated review of information of Genus Berberis species reported to date regarding their ethnomedicinal information, chemical constituents, traditional/folklore use, and reported pharmacological activities on more than 40 species of Berberis. Conclusion: A comprehensive survey of the literature reveals that various species of the genus possess various phytoconstituents mainly alkaloids, flavonoid based compounds isolated from different parts of a plant with a wide range of pharmacological activities. So far, many pharmacological activities like anti-cancer, anti-hyperlipidemic, hepatoprotective, immunomodulatory, anti-inflammatory both in vitro & in vivo and clinical study of different extracts/isolated compounds of different species of Berberis have been reported, proving their importance as a medicinal plant and claiming their traditional use.

Current Status and Future Perspective for Research on Medicinal Plants with Anticancerous Activity and Minimum Cytotoxic Value

2019 ◽  
Vol 20 (12) ◽  
pp. 1227-1243
Author(s):  
Hina Qamar ◽  
Sumbul Rehman ◽  
D.K. Chauhan
Keyword(s):  
Side Effects ◽  
Medicinal Plants ◽  
Anticancer Agents ◽  
Drug Targets ◽  
Psidium Guajava ◽  
Current Status ◽  
Future Perspective ◽  
Wide Range

Cancer is the second leading cause of morbidity and mortality worldwide. Although chemotherapy and radiotherapy enhance the survival rate of cancerous patients but they have several acute toxic effects. Therefore, there is a need to search for new anticancer agents having better efficacy and lesser side effects. In this regard, herbal treatment is found to be a safe method for treating and preventing cancer. Here, an attempt has been made to screen some less explored medicinal plants like Ammania baccifera, Asclepias curassavica, Azadarichta indica, Butea monosperma, Croton tiglium, Hedera nepalensis, Jatropha curcas, Momordica charantia, Moringa oleifera, Psidium guajava, etc. having potent anticancer activity with minimum cytotoxic value (IC50 >3μM) and lesser or negligible toxicity. They are rich in active phytochemicals with a wide range of drug targets. In this study, these medicinal plants were evaluated for dose-dependent cytotoxicological studies via in vitro MTT assay and in vivo tumor models along with some more plants which are reported to have IC50 value in the range of 0.019-0.528 mg/ml. The findings indicate that these plants inhibit tumor growth by their antiproliferative, pro-apoptotic, anti-metastatic and anti-angiogenic molecular targets. They are widely used because of their easy availability, affordable price and having no or sometimes minimal side effects. This review provides a baseline for the discovery of anticancer drugs from medicinal plants having minimum cytotoxic value with minimal side effects and establishment of their analogues for the welfare of mankind.

Approach in improving potency and selectivity of kinase inhibitors: Allosteric kinase inhibitors

2020 ◽  
Vol 21 ◽  
Author(s):  
Shangfei Wei ◽  
Tianming Zhao ◽  
Jie Wang ◽  
Xin Zhai
Keyword(s):  
Protein Interactions ◽  
Kinase Inhibitors ◽  
Binding Modes ◽  
Allosteric Inhibitors ◽  
Wide Range ◽  
Allosteric Sites ◽  
Protein Functions ◽  
Regulate Protein

: Allostery is an efficient and particular regulatory mechanism to regulate protein functions. Different from conserved orthosteric sites, allosteric sites have distinctive functional mechanism to form the complex regulatory network. In drug discovery, kinase inhibitors targeting the allosteric pockets have received extensive attention for the advantages of high selectivity and low toxicity. The approval of trametinib as the first allosteric inhibitor validated that allosteric inhibitors could be used as effective therapeutic drugs for treatment of diseases. To date, a wide range of allosteric inhibitors have been identified. In this perspective, we outline different binding modes and potential advantages of allosteric inhibitors. In the meantime, the research processes of typical and novel allosteric inhibitors are described briefly in terms of structureactivity relationships, ligand-protein interactions and in vitro and in vivo activity. Additionally, challenges as well as opportunities are presented.

Sign in / Sign up

Export Citation Format

Share Document